Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyorgy Bagdy

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|February 8, 2018
[Genetic association analyses of the endocannabinoid system on anxious phenotype]Judit Lazary, Nora Eszlari, Gabriella Juhasz, et al.
Trends in Pharmacological Sciences|April 19, 2011
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonistsJudit Lazary, Gabriella Juhasz, Laszlo Hunyady, et al.
Pharmacology|January 24, 2019
Blockade of Serotonin 2C Receptors with SB-242084 Moderates Reduced Locomotor Activity and Rearing by Cannabinoid 1 Receptor Antagonist AM-251Emese Bogáthy, Diana Kostyalik, Peter Petschner, et al.
Neuroscience Letters|March 31, 2004
Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsyMarton Graf, Rita Jakus, Sandor Kantor, et al.
Translational Psychiatry|March 29, 2025
Genome-wide by trait interaction analyses with neuroticism reveal chronic pain-associated depression as a distinct genetic subtypeSandor Krause, Dora Torok, Gyorgy Bagdy, et al.
British Journal of Pharmacology|July 22, 2004
Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505Sandor Kantor, Rita Jakus, Brigitta Balogh, et al.
Brain Research|June 29, 2002
Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shiftSandor Kantor, Rita Jakus, Robert Bodizs, et al.
Headache|February 27, 2003
Effect of autogenic training on drug consumption in patients with primary headache: an 8-month follow-up studyTerezia Zsombok, Gabriella Juhasz, Agota Budavari, et al.
Journal of Affective Disorders|July 9, 2005
Subthreshold depression is linked to the functional polymorphism of the 5HT transporter geneXenia Gonda, Gabriella Juhasz, Andras Laszik, et al.
Psychiatry Research|November 23, 2006
High anxiety and migraine are associated with the s allele of the 5HTTLPR gene polymorphismXenia Gonda, Zoltan Rihmer, Gabriella Juhasz, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|February 8, 2018
[Genetic association analyses of the endocannabinoid system on anxious phenotype]Judit Lazary, Nora Eszlari, Gabriella Juhasz, et al.
Trends in Pharmacological Sciences|April 19, 2011
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonistsJudit Lazary, Gabriella Juhasz, Laszlo Hunyady, et al.
Pharmacology|January 24, 2019
Blockade of Serotonin 2C Receptors with SB-242084 Moderates Reduced Locomotor Activity and Rearing by Cannabinoid 1 Receptor Antagonist AM-251Emese Bogáthy, Diana Kostyalik, Peter Petschner, et al.
Neuroscience Letters|March 31, 2004
Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsyMarton Graf, Rita Jakus, Sandor Kantor, et al.
Translational Psychiatry|March 29, 2025
Genome-wide by trait interaction analyses with neuroticism reveal chronic pain-associated depression as a distinct genetic subtypeSandor Krause, Dora Torok, Gyorgy Bagdy, et al.
British Journal of Pharmacology|July 22, 2004
Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505Sandor Kantor, Rita Jakus, Brigitta Balogh, et al.
Brain Research|June 29, 2002
Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shiftSandor Kantor, Rita Jakus, Robert Bodizs, et al.
Headache|February 27, 2003
Effect of autogenic training on drug consumption in patients with primary headache: an 8-month follow-up studyTerezia Zsombok, Gabriella Juhasz, Agota Budavari, et al.
Journal of Affective Disorders|July 9, 2005
Subthreshold depression is linked to the functional polymorphism of the 5HT transporter geneXenia Gonda, Gabriella Juhasz, Andras Laszik, et al.
Psychiatry Research|November 23, 2006
High anxiety and migraine are associated with the s allele of the 5HTTLPR gene polymorphismXenia Gonda, Zoltan Rihmer, Gabriella Juhasz, et al.
Pageof 12